"The Clinician-Teacher Development Award was the foundation and opportunity I needed to start my research in health care disparities. I certainly would not be where I am today if it was not for this award and the support the CDI offered me and has continued to provide."
Marcela del Carmen, MD
Chief Medical Officer, Massachusetts General Physicians Organization (MGPO)
2005 CTDA Winner

2021 Clinician-Teacher Development Award Recipients

Paula A. AduenPaula A. Aduen, PhD
Department of Psychiatry
Massachusetts General Hospital Multicultural Assessment and Research Center
Massachusetts General Hospital Multicultural Alzheimer’s Prevention Program
Instructor, Harvard Medical School

Dr. Aduen is a Clinical Neuropsychologist within the Massachusetts General Hospital Department of Psychiatry, junior research faculty in the Multicultural Alzheimer’s Prevention Program (MAPP), and is an Instructor in Psychology at Harvard Medical School. She serves as Assistant Director of the Multicultural Assessment and Research Center (MARC). She received her doctoral degree in Clinical Psychology from the University of Virginia. She completed her psychology residency at the University of Chicago Medicine and post-doctoral fellowship in clinical neuropsychology at the Harvard Partners Consortium (Massachusetts General Hospital/Brigham and Women's Hospital/HMS).

Dr. Aduen's primary clinical interests are in aging, neurodegenerative diseases, and multicultural neuropsychology. She is committed to serving historically underrepresented communities through promoting greater accessibility and providing culturally-sound practices in neuropsychology to the Latino community. At MGH MARC, she provides neuropsychological evaluations to culturally and linguistically diverse adult patients presenting with a range of cognitive concerns. Dr. Aduen has dedicated most of her research career to examining the relationship between cognition, behavior, and functional outcomes in neurodevelopmental, neurological, and neurodegenerative disorders. Currently, her research interests include development and validation of neuropsychological instruments sensitive to pre-clinical cognitive change in Alzheimer’s disease, as well as, understanding chronic and cumulative life stress as a risk factor for cognitive decline among Latinos. She is passionate about the translatability of these findings to aid in the identification and operationalization of modifiable risk factors that place Latinos at greater risk for accelerated aging and dementia.

Abstract: Chronic Stress as a Risk Factor for Age-Related Cognitive Decline in Latinos

Prevalence rates of Alzheimer’s disease and related dementias (ADRD) are greater among older Latinos and African Americans compared to their White-Caucasian counterparts. While it is well established that older age and family history are risk factors for ADRD and accelerated aging, there has been increasing interest in identifying potentially modifiable lifestyle factors to mitigate risk among vulnerable populations. It has been estimated that about 40 % of the risk to develop ADRD could be reduced by modifying lifestyle factors. Chronic stress, both psychological and biological, emerges as a strong candidate factor for exploration given its association with adverse health outcomes, which in turn impact aging and cognition. Given several psychosocial factors associated with immigration- and acculturation-related stress, it is unsurprising that Latino immigrants are particularly at risk for adverse health consequences from chronic stress. As such, investigating whether chronic stress impacts cognitive decline, and overall risk for ADRD in older Latinos is pivotal to improve prevention, early detection, and development of novel treatments and interventions for this critically underserved and understudied population. This will be one of the first studies to examine chronic stress, through a multi-pronged assessment approach utilizing both psychological constructs and biological measures of stress, as a risk factor for cognitive decline in older Latinos. The precise and thorough measurement approach to this study is undoubtedly a strength that will help clinicians understand at which facet of stress a potential intervention is plausible and meaningful.

Onyinyechi F. EkeOnyinyechi F. Eke, MD
Department of Emergency Medicine, Division of Emergency Ultrasound
Director, Global Ultrasound
Instructor in Emergency Medicine, Harvard Medical School

Dr. Eke is an emergency medicine physician and Director of Global Ultrasound in the Department of Emergency Medicine at Massachusetts General Hospital. She received her undergraduate degree from the University of Maryland, College Park and medical degree from Johns Hopkins School of Medicine, Baltimore. Dr Eke completed emergency medicine residency training at Cook County Hospital, Chicago and fellowship in emergency ultrasound at Massachusetts General Hospital. Dr Eke is a national and international point-of-care ultrasound educator. In 2020, she received the Academy of Emergency Ultrasound Fellow Education Award by the Society for Academic Emergency Medicine. Her research focus is the development of point-of-care ultrasound education and training in resource-limited settings, particularly in Sub-Saharan Africa, and the efficient utilization of point-of-care ultrasound to facilitate patient care in the emergency department.

Abstract: Implementation of Tele-ultrasound in an Academic Emergency Department: A Study of Feasibility, Acceptability and Clinical Impact

Point-of-care ultrasound is a clinically efficient and cost-effective diagnostic modality used in the delivery of care to patients in the emergency department. Its optimum use is dependent on adequate training and proficiency of its users; however, this competency can be variable, even in a tertiary care emergency department. Preliminary data collected at Massachusetts General Hospital show that further support is needed among emergency department clinical providers when using point-of-care ultrasound clinically. This project aims to use tele-ultrasound, remote expert support for ultrasound use and interpretation, to fill this need and to improve point-of-care ultrasound utility in the emergency department, thus improving clinical workflow and patient care. The proposed research will begin with a baseline assessment of point-of-care ultrasound utilization according to the RE-AIM implementation framework. This data along with qualitative interviews will be used to optimize the implementation strategy for tele-ultrasound that will then be assessed through repeat assessment with the RE-AIM framework in a hybrid type II clinical effectiveness implementation evaluation.

Jona LudmirJona Ludmir, MD
Cardiology Division
Corrigan Minehan Heart Center
Instructor in Medicine, Harvard Medical School

Dr. Ludmir is a critical care cardiologist at the Corrigan Minehan Heart Center ICU at Mass General. He is also an instructor of medicine at Harvard Medical School. Dr. Ludmir received his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine and pediatrics at the Hospital of the University of Pennsylvania and the Children’s Hospital of Philadelphia, cardiology fellowship at the University of Maryland Medical Center, and critical care fellowship at Stanford University Medical Center. Dr. Ludmir specializes in cardiac intensive care, critical care echocardiography, and heart disease prevention. Dr. Ludmir is the lead physician for the family-centered care initiated in the Heart Center ICU, where he focuses on incorporating evidence-based guidelines for family-centered cardiovascular care delivery. His research interests include optimizing communication in the ICU, developing family support strategies in the ICU, and improving cardiovascular healthcare disparities.

Abstract: The Hispanic Acute Myocardial Infarction Discharge Intervention Study (HAMIDI)

Hispanic patients experience disproportionate challenges in accessing cardiovascular care, including in the setting of acute myocardial infarction (AMI). The delay in care often begins with lack of understanding and recognition of AMI symptoms, thereby delaying activation of 911 and hospital presentation. Compared with non-Hispanic white patients, Hispanic patients experience delays in the initial triage and reperfusion in the setting of AMI. While in-hospital mortality across Hispanic and non-Hispanic white patients post-AMI is similar, young Hispanic women experience higher in-hospital mortality compared with young white men. The healthcare disparities persist post-AMI discharge, in particular with 30-day readmission rates and cardiac rehabilitation referrals. Because of the challenges Hispanic patients face with post-AMI care, the Hispanic Acute Myocardial Infarction Discharge Intervention Study (HAMIDI) aims to provide a culturally sensitive discharge framework in hopes of improving readmission rates and cardiovascular health metrics. Patients enrolled in this study will participate in a comprehensive post-discharge program, involving follow-up with a Spanish-speaking cardiologist within two weeks post-discharge, cardiac rehabilitation, and a four-part educational group visit program.

Prior Year Award Recipients


Katia M. CanenguezKatia M. Canenguez, PhD, EdM
Department of Psychiatry
Pediatric/Congenital Cardiology and Raising Healthy Heart Program
Partners Pediatric Multiple Sclerosis
Harvard / Massachusetts General Hospital Center on Genomics, Vulnerable Populations, and Health Disparities, Mongan Institute Health Policy Center
Instructor, Harvard Medical School

Dr. Canenguez is a Pediatric Psychologist in the Division of Child and Adolescent Psychiatry at the Massachusetts General Hospital (MGH)/MassGeneral for Children and an Instructor in the Department of Psychiatry at Harvard Medical School (HMS). She is also a Clinical Researcher at the Harvard/MGH Center on Genomics, Vulnerable Populations, and Health Disparities. Dr. Canenguez earned her BA from Boston College, EdM from Harvard University, and her PhD from the University of Massachusetts, Boston. She completed her pre-doctoral internship and post-doctoral fellowship at MGH/HMS.

Dr. Canenguez is interested in the intersection of health, mental health and education with a focus on equity and developing and delivering culturally sensitive evidence-based prevention and interventions. Her clinical expertise is in pediatric behavioral medicine. She provides treatment for patients of diverse backgrounds managing anxiety, depression, trauma, and adjustment issues, often with comorbid medical conditions. Her research interests include behavioral health disparities, resilience, acculturation, spirituality, community mental health, global health, evidence-based interventions to promote well-being, and research for policy change.

Dr. Canenguez is passionate about mentorship, youth empowerment and community service. Her awards include the Greater Boston YMCA’s Achiever Award for outstanding professional accomplishments and commitment to community service, and the Greater Boston YMCA’s Career Cluster Leadership Award in recognition of her collaboration in developing the Health and Medical Sciences career cluster curriculum. She has also been a recipient of the MGH Ernesto Gonzales award for outstanding service to the Latino/a community.

Abstract: Development and Evaluation of a Resiliency Curriculum: Racial Identity, Racial Justice and Youth Equity

Black, Indigenous and People of Color (BIPOC) can experience high and prolonged levels of stress due to issues of racism and discrimination. Despite studies documenting the negative associations between microaggressions and discriminatory behaviors with health, mental health, and educational outcomes, there remains a lack of programming to ameliorate the potential negative impact of these experiences. 

Research suggests that resiliency strategies based on racial identity development principles can enhance coping strategies to manage stress and promote positive well-being of BIPOC youth, with the potential for enhancing school success.  Our study will evaluate the Racial Identity/Racial Justice Youth Equity and Resiliency Curriculum developed by Drs. Katia Canenguez and Jonathan Jenkins.

The curriculum is designed to support youth affirm their racial and ethnic identities with pride, to have confidence in their intellect and build resiliency. The program also emphasizes empowering youth as positive assets for society, not only as individuals but also as potential agents of positive social change.

As part of this study, MGH Youth Scholars will participate in qualitative interviews to share their views on issues of race and ethnicity and to provide feedback on the curriculum. MGH Youth Scholars will also complete pre- and post- surveys to evaluate the impact of the manualized curriculum on physical and mental health, as well as educational outcomes. Findings from the study will inform the final manualized curriculum, which will be disseminated widely to various stakeholder groups, including schools and youth-focused community organizations.


Carlos Torres, MD

Carlos Torres, MD
Department of Pediatrics, MGH Chelsea HealthCenter
Associate Director of Diversity & Inclusion, MassGeneral Hospital for Children
Instructor in Pediatrics, Harvard Medical School

Dr. Torres is a pediatrician at MGH Chelsea HealthCare Center and Associate Director of Diversity & Equity at MassGeneral Hospital for Children. He was born and raised in Guadalajara, Jalisco, Mexico. He moved with his family to Milwaukee, Wisconsin during his teenage years, afterwards attending the University of Wisconsin-Madison and earning his bachelor of science in psychology. He received his Doctor of Medicine from Harvard Medical School, then attended pediatric residency at MassGeneral Hospital for Children and served as a chief resident. His clinical and research interests include immigrant health, disparity research, LGBT health, and resiliency. Outside of work, he enjoys spending time with his partner and dog, catching up with his nine siblings and many nephews back home, traveling, and gardening.

Abstract: Implementing and evaluating a longitudinal, interdepartmental cross-cultural care curriculum in pediatrics for residents, attendings, and nurses

Medical trainees must learn to competently care for patients from different cultures. However, a standardized curriculum that teaches cross-cultural care and which has been evaluated for efficacy does not exist in pediatrics at MassGeneral Hospital for Children (MGHfC). This project aims to develop, implement, and evaluate a cross-cultural care curriculum in pediatrics, adapting to our current needs. Through this curriculum, participants will be able to recognize that cross-cultural education is a vehicle for enhancing the quality of patient care and building effective healthcare teams, apply practical guidelines to communicate effectively across cultures, and use their own cultural identity as an asset to define the social and cultural issues that are most relevant in the care of diverse patient populations. This curriculum will enable all providers to change their approach to cross-cultural care through reflection on their current practice and active discussion and training of new language and attitudes. Ultimately, the intent is to create and distribute an evidence-based curriculum that can be delivered to the entire department at MGHfC, including attendings and nurses, so that it can increase clinicians’ preparedness and competency in caring for a diverse community of patients.

Soo Jeong Young, PhD

Soo Jeong Youn, PhD
Department of Psychiatry, Massachusetts General Hospital
Director of Evaluation and Clinical Psychologist, Community Psychiatry Program for Research in Implementation and Dissemination of Evidence-based Treatments (PRIDE)
Assistant Professor in Psychiatry, Harvard Medical School

Dr. Youn is the Director of Evaluation and a Clinical Psychologist at Community Psychiatry Program for Research in Implementation and Dissemination of Evidence-Based Treatments (PRIDE) at Massachusetts General Hospital. She is also an Assistant Professor in Psychiatry at Harvard Medical School. Dr. Youn completed her PhD in Clinical Psychology at The Pennsylvania State University, and her Clinical Internship at Massachusetts Mental Health Center, Beth Israel Deaconess Medical Center/Harvard Medical School in 2017.

Dr. Youn’s research and clinical focus include addressing the access-to-care problem and health disparities that exist in mental health and disproportionately impact underserved populations. Her clinical and research endeavors focus on the adaptation of evidence-based practices, and the development of implementation, dissemination and scalable models of these interventions for diverse systems and communities. Dr. Youn has extensive experience conducting clinical care and research in community health centers and working with paraprofessionals as a novel workforce in delivering evidence-based practices.

Abstract: Bridging the science-practice gap by creating a community participatory teaching program

One out of every five youth in the United States has a mental health disorder, yet more than 80% of youth in the United States do not receive any mental health care, with a higher unmet need among ethnically diverse youth. Evidence-based treatments, such as Cognitive Behavioral Therapy (CBT), have been shown to effectively address mental health disorders among youth, and schools have become an important setting for these interventions. However, it takes at least 17 years for these treatments to reach settings like schools, often longer for those in underserved communities. In addition, schools often lack trained personnel that can adequately meet the mental health needs of students. As such, the aim of this proposal is to bridge this science-practice gap by creating a community participatory teaching program that will train teachers working in inner-city high schools to better utilize cognitive behavioral strategies to serve the mental health needs of their students. This will be accomplished by adapting a program for teachers in CBT interventions to include case conceptualization and group management and providing ongoing training and coaching to teachers to utilize their newly acquired skillset.


Adeline Boatin, MD, MPHAdeline Boatin, MD, MPH
Vincent Department of Obstetrics and Gynecology
Global Health Director, Vincent Department of Obstetrics and Gynecology
Affiliate, Program for Global Surgery and Social Change
Assistant Professor Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School 

Dr. Boatin is a clinician, researcher and educator at Harvard Medical School and Massachusetts General Hospital in Boston, USA. She received her undergraduate education at Harvard University and her medical degree at the College of Physicians and Surgeons University.

She completed an MPH with a focus on international health at the Harvard School of Public Health and then completed a four-year residency in Obstetrics and Gynecology at Harvard. She is currently an Assistant Professor in Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She is affiliate faculty at the Program for Global Surgery and Social Change at Harvard Medical School and the Center for Global Health at MGH. In addition to clinical care and resident training at MGH, she is an NIH-funded clinical researcher with a focus on reducing global reproductive health inequities, particularly around the provision of safe and quality surgery. Her current research focuses on using wireless monitoring technology to overcome human resource limitations in post-operative care and the spectrum of quality of care around obstetric surgery in low and middle-income countries.

Abstract: A Hybrid Effectiveness-Implementation Study of Wireless Physiologic Monitoring among Postpartum Women in Uganda

Women in sub-Saharan Africa have the highest rates of morbidity and mortality during childbirth. Despite significant increases in facility-based childbirth, quality gaps at the facility have limited reductions in maternal deaths. Infrequent monitoring of women around childbirth is a major gap in care that leads to delays in life-saving interventions. Simple increases in staffing will not overcome this gap, thus necessitating new strategies. This project aims to use a simple wireless monitor to improve the detection of complications immediately after childbirth and allow clinicians to provide life-saving interventions when needed. Using a hybrid clinical effectiveness-implementation approach women delivered by cesarean in Mbarara, Uganda will be recruited to wear a wireless physiologic monitor for 24 hours after delivery and their delivering obstetricians recruited to use the monitoring system, including the receipt of text message alerts should women develop abnormalities in physiologic signs. Rates of morbidity and mortality will be compared with a control group of women delivered by the same obstetricians. Clinical adoption and implementation will be assessed with the RE-AIM implementation framework and semi-structured interviews. Research findings will form the basis for an NIH R01 application for a cluster randomized-control trial aiming to reduce maternal morbidity and mortality during facility-based childbirth in RLS through implementation of wireless physiologic monitoring.

Renee N. Salas, MD, MPH, MSRenee N. Salas, MD, MPH, MS
Department of Emergency Medicine, Center for Social Justice and Health Equity
Assistant Professor in Emergency Medicine, Harvard Medical School
Yerby Fellow, Center for Climate, Health, and the Global Environment, Harvard T.H. Chan School of Public Health
Affiliated Faculty, Harvard Global Health Institute

Dr. Salas is an emergency medicine physician with an academic focus on the intersection of climate change, health, and health care. She received her Doctor of Medicine from the innovative five-year medical school program to train physician-investigators at the Cleveland Clinic Lerner College of Medicine. She concurrently obtained a Master of Science in Clinical Research from Case Western Reserve University School of Medicine. Subsequently, she matriculated to the University of Cincinnati for a four-year emergency medicine residency. She completed a two-year wilderness medicine fellowship at Massachusetts General Hospital and graduated with a Master of Public Health from the Harvard T.H. Chan School of Public Health, with a concentration in environmental health, in 2016.

Dr. Salas has served as the lead author for the Lancet Countdown on Health and Climate Change Brief for the United States since 2018 and founded the associated Working Group. Dr. Salas was a Co-Director for the first Climate Crisis and Clinical Practice Symposium and spearheads the broader Initiative in partnership with The New England Journal of Medicine. She alsoserved on the planning committee for the National Academy of Medicine’s Climate Change and Human Health Grand Challenge and has testified before Congress for the full House Committee on Oversight and Reform on how climate change is harming health. She engages in research on how climate change is impacting the health care system and developing evidence-based adaptation. She lectures on climate and health nationally and internationally, has published in high-impact journals, and her work and expertise has been featured in mainstream media outlets like the New York Times, NPR, Time, and the Associated Press.

Abstract: Impact of Billion-Dollar Weather and Climate Disasters on Healthcare Utilization, Outcomes, and Cost for Elderly Medicare Beneficiaries - Implications for Educational, Community Service, and Advocacy Initiatives

There is consensus that climate change is the largest public health threat of our time. While climate change threatens health through numerous ways, one key pathway is increasing the frequency and/or severity of extreme weather events. Yet, there are relatively few systematic and comprehensive assessments of the impacts on individuals and health systems. This type of understanding is critical to inform educational, community service, and advocacy efforts. This project seeks to address this knowledge gap by characterizing the impact of extreme weather disasters on the utilization of healthcare and health outcomes for elderly Medicare beneficiaries, with a key focus on translating this knowledge to adaptation and climate resiliency strategies. The extreme weather disasters will be identified from publicly available data from the National Oceanic and Atmospheric Administration. We will then evaluate the impact of these events on healthcare utilization, outcomes, and costs using national Medicare data, focusing on older Americans who are especially vulnerable to the negative health impacts of extreme weather events. This approach will help us better understand the broader health and economic costs associated with extreme weather events. Most importantly, it will allow the development of targeted interventions for the elderly, improve hospital disaster preparedness plans, and engage key healthcare stakeholders in the climate change and health discussion.


Marcelo Matiello, MD, MSc

Marcelo Matiello, MD, MSc
Department of Neurology 
Director, Neurology Inpatient Services; Routine and Urgent Teleneurology Program 
Assistant Professor of Neurology, Harvard Medical School

Dr. Matiello completed his Doctorate of Medicine at the Federal University of Rio de Janeiro, Brazil, where he also completed his initial residency training in Neurology and Internal Medicine. He joined the Mayo Clinic in 2006, completed two research fellowships in genetics and molecular mechanisms of neuromyelitis optica and multiple sclerosis. At the Mayo Clinic Graduate School of Medicine he obtained his Master of Science in Clinical and Translational Research. In 2012, he went to Yale University, where he spent one year on residency training and then in 2016 completed three years of neurology residency at MGH. In 2017 he completed the American Academy of Neurology Medical Education Fellowship. He has authored over 50 peer-reviewed manuscripts, review articles or book chapters. Dr. Matiello is a fellow for the Multiple Sclerosis International Foundation and the of National Multiple Sclerosis Society, and is a member of the American Academy of Neurology, the Mayo Clinic Alumni Association and of Scientific consortium of the NMO foundation. He has presented his work in 21 countries. He has been awarded with the Mayo Clinic Neurology Award (2010), the European Committee for the Treatment and Research in Multiple Sclerosis award (2012), Yale Hospital Outstanding House Staff Award (2013) and the Harvard Neurology Medical Education Scholar (2015), MGH Child Neurology award (2016), The MGH Bowditch Award (2018).

Abstract: The Harvard-MGH Neurology Online Case-Based Learning System System Development and Educational Outcomes Research

The detailed study of clinical cases plays an essential role in the education of medical students, residents and fellows. Research has demonstrated that development of expertise is closely associated with case experience, and that using cases as the core of the instruction will activate prior knowledge and provide better context for learning. Our overall hypothesis is that a neurology case-based online learning system is feasible and superior to current self-learning strategies in leading to improved perception and educational outcomes related to neurology. We propose to develop, implement and test the education outcomes of the innovative Harvard E-Neuro online case-based learning system. We will also develop the editorial board in which neurology residents will have key leadership roles. We aim to determine the feasibility of implementing an innovative and comprehensive neurology online case-based database and curriculum management system, to determine whether the resident editorial system for case preparation and online publishing into the learning system will lead to improved neurology resident scholarly production, and finally, we aim to determine whether the utilization of the online case-based learning system will lead to better education outcomes. There is no similar learning system in neurology. An important novel aspect of our proposal is that by development of such learning system, the process itself teaches the residents and fosters mentoring for clinical education and scholarship.

Nicole L. Mazwi, MD

Nicole L. Mazwi, MD
Department of Physical Medicine & Rehabilitation, Spaulding Rehabilitation Hospital 
Department of Physical Medicine and Rehabilitation Service, Massachusetts General Hospital 
Instructor in Physical Medicine and Rehabilitation, Harvard Medical School

Dr. Mazwi received her medical degree from the Mayo Clinic in Rochester, Minnesota. She completed her internship at the Johns Hopkins Hospital/Sinai Hospital of Baltimore Internal Medicine Residency program and her Physical Medicine and Rehabilitation residency at the Spaulding Rehabilitation Hospital (SRH)/Harvard Medical School program where she was Chief Resident. Dr. Mazwi completed a fellowship in Neurologic Rehabilitation at SRH and Massachusetts General Hospital (MGH) and joined the staff at both hospitals in 2012. Dr. Mazwi is the first-ever dedicated consult physiatrist in the MGH Neurologic Intensive Care Unit. Since 2014 she has served as Co-Director of the Harvard Medical School Brain Injury Medicine Fellowship Program at SRH and MGH. She is the also the Co-Director of the new Parters Neurorecovery fellowship at MGH and SRH. She is a Neurotrauma Consultant for the National Football League and in her free time she volunteers for the Boston Ballet Company as an in-house physician – just in case anyone has a less than perfect landing.

Abstract: Time to Move: Ideal Mobility Dose in Critically Ill Stroke Patients

Immobility associated with being hospitalized contributes significantly to prolonged recovery through a variety of mechanisms, including deconditioning. This may be particularly true for neurological patients, who additionally deal with motor and sensory deficits from their underlying condition. Recent data indicates that early mobilization in surgical intensive care units is helpful in decreasing ICU length of stay and improving functional mobility at hospital discharge. The impact of early mobilization in critically ill stroke patients remains unclear. In the ischemic stroke population evidence suggests that very early mobilization (<6 hours) may be harmful, while early mobilization after 24 hours is beneficial. As an intervention, early mobilization is affordable, widely applicable and can be utilized in all care environments. It has the potential to be a significant and cost effective method of improving outcomes for neurological patients, but a greater understanding of this intervention is needed. This study aims to assess the safety of early mobilization in critically ill patients with ischemic and hemorrhagic stroke. Further, the study will evaluate its effect on discharge disposition and functional outcomes and determine the ideal mobilization for this population. The study will ultimately provide data for a randomized, multicenter trial to follow. The implications could be practice-changing for neurologic intensive care approaches of the future.


Arianne Shadi Kourosh, MDArianne Shadi Kourosh, MD
Department of Dermatology 
Director, Community Health for the Department of Dermatology 
Instructor in Dermatology, Harvard Medical School

Dr. Kourosh is a board-certified dermatologist and Assistant Professor of Dermatology at Harvard Medical School. She is a graduate of the Harvard School of Public Health and the University of Texas Southwestern Medical Center, where she received the institution's awards for Leadership and Outstanding Professionalism and Humanism as a physician.

Dr. Kourosh is committed to patient advocacy and solving public health problems for patients with skin disease. She developed the Skin Advocate iPhone App, a free iPhone application that connects patients with patient advocacy organizations for their skin conditions. She has served as Editor-in-Chief of Dialogues in Dermatology, the American Academy of Dermatology's (AAD) official podcast and internationally subscribed educational program for physicians.

Dr. Kourosh serves as the Dermatology Department's Director of Community Health, providing access to dermatologic care for underserved communities. She is the founding director of the Clinic for Pigmentary Disorders at Massachusetts General Hospital, and the founder and director of Project Phoenix, MGH's pro-bono tattoo removal program, assisting those escaping gangs and human trafficking to be safe and reintegrate into society, which has won national awards for its impact. She also advocates for patients at the national level in the AAD's delegation to Congress to protect medical research and affordable care for patients with skin disease.

Dr. Kourosh has won numerous awards including Massachusetts General Hospital's Clinician-Teacher Award, Harvard Medical School's Dean's Community Service Award, and the Ernesto Gonzalez Award for outstanding service to the Latino Community. In 2020 she received the AAD's Presidential Citation for outstanding service during the COVID19 crisis and was named one of Medscape's 25 Rising Stars in Medicine.

Abstract: Avatoras - A Novel Teledermatology Interface to Address Access and Compliance Barriers in Dermatology

Skin problems affect people of all ages and all backgrounds. However due to a shortage of dermatologists in some parts of the country patients, especially those of underserved backgrounds have to wait months to be seen. Thus, new and creative methods of providing care for patients with skin problems in dermatology are needed.

Dr. Kourosh has designed a system of delivering healthcare for these patients called “Avatoras” where follow-up visits for skin disease can be conducted by medical assistants (MA) and community health workers (CHWs) through video- conferencing with patients as an animated character who serves as their health coach on their computers and mobile phones in their homes. This could save time and money for patients and the healthcare system by minimizing unnecessary doctor visits for stable skin conditions.

The purpose of the project is to determine if this new model of delivering healthcare for pediatric atopic dermatitis (AD) can provide equal quality of care and patient satisfaction compared with in person doctor visits, and thus to determine if it can serve as a practical and cost-effective option for visits for patients with skin conditions who face barriers in obtaining dermatologic care.

Josanna M. Rodriguez-Lopez, MDJosanna M. Rodriguez-Lopez, MD
Department of Medicine, Pulmonary and Critical Care Division
Associate Director, Pulmonary Hypertension and Thromboendarterectomy Program
Director, Hereditary Hemorrhagic Telangectasia Center
Instructor in Medicine, Harvard Medical School

Dr. Rodriguez-Lopez graduated Magna Cum Laude from Boston College in 2000, majoring in French and Biology. She obtained her MD from New York University School of Medicine in 2004. She performed her Residency and Fellowship at Columbia University.

In January 2013, she was recruited by Dr. Richard Channick to help develop the Pulmonary Hypertension and Thromboendarterectomy Program. In this role she was able to supervise patient care and develop expertise in diagnosing and treating patients with chronic thromboembolic pulmonary hypertension (CTEPH), a rare complication after pulmonary embolism caused by chronic organized thrombi which obstruct the pulmonary vasculature.

In addition, she helped form the multi-disciplinary initiative Pulmonary Embolism Response Team (PERT), which was spearheaded at MGH to improve the coordination and care of patients with acute pulmonary embolism. She also helped establish the PERT follow-up clinic for the long-term management of these patients. It has become apparent to her that many patients following acute pulmonary embolism have residual shortness of breath and exercise limitation, a term referred to as post PE syndrome.

Abstract: Redefining Post Pulmonary Embolism Syndrome: The Association between Residual Thrombus, Exercise Impairment, and Quality of Life

Pulmonary embolism (PE) is a common but serious condition that affects up to half a million people each year in the United States. It is caused by blood clots that travels to the arteries of the lungs and can block blood flow. Despite adequate treatment with blood thinners, some people will still experience debilitating symptoms of shortness of breath and exercise intolerance following a PE. This phenomenon, termed post PE syndrome, is not completely understood and is commonly missed by physicians. With this project, they plan to implement a standard diagnostic algorithm for patients with persistent shortness of breath after a PE. Patients who have symptoms four to eight weeks after being on treatment for their PE will undergo further testing with repeat imaging and cardiopulmonary testing. This will allow us to identify post PE syndrome early and will help elucidate the causes of exercise impairment and shortness of breath in these patients. This study will identify the incidence of post PE syndrome and will clarify whether it is caused by chronic persistent blood clots, subtle heart dysfunction, or something else. This will allow us to better care for these patients and try to target their treatment appropriately. The data obtained from the follow up clinic will also help create guidelines for how to best care for PE patients after their acute event.


Ersne Eromo, MD, MBAErsne Eromo, MD, MBA
Department of Anesthesia, Critical Care and Pain Medicine 
Instructor in Anesthesia, Harvard Medical School

Dr. Eromo graduated with a BS in Biology from the University of California, Los Angeles in 2003 (magna cum laude and Phi Beta Kappa) and completed a combined MD/MBA program in 2009 at the David Geffen School of Medicine at UCLA (Alpha Omega Alpha) and the UCLA Anderson School of Management. Upon graduating from medical school, she completed a surgical internship at the Harbor-UCLA Medical Center in Torrance, California before moving to Boston where she trained in anesthesiology in the Mass General Department of Anesthesia, Critical Care and Pain Medicine. She completed residency in September 2013 and has been on the faculty at Mass General since October 2013.As staff, Dr. Eromo has been involved in all aspects of resident education and is currently co-coordinator for curriculum design for the Basic Board Review sessions for anesthesiology residents and the clerkship director for Harvard Medical Students. She is also on the Mass General anesthesiology department’s Education Committee and the Clinical Competency Committee. As of July 2014, Dr. Eromo is a Simulation Fellow with the Mass General Learning Lab and the American College of Surgeons and has been heavily involved in the in-situ intra-operative team simulation training for crisis management at Mass General.

Abstract: A “Gap”-driven Crisis Event Simulation Curriculum for Anesthesiology Residents


Tanishia Choice, MDTanishia Choice, MD
Department of Psychiatry, Division of Child and Adolescent Psychiatry, Mass General
Lecturer in Psychiatry, Harvard Medical School

Dr. Choice completed her fellowship in Child and Adolescent Psychiatry at Mass General/McLean hospitals in June 2014. She was clinical faculty at Mass General from July 2014 to July 2018, when she worked in the Mass General outpatient child psychiatry clinic, the Mass General MCPAP (Massachusetts Child Psychiatry Program) clinic, a clinic that provides outpatient psychiatric consultation to pediatrics, and served as a psychiatry consultant to the Mass General Center for Neurointestinal Health. She currently serves as adjunct clinical faculty at Mass General supervising and teaching general psychiatry residents and child psychiatry fellows. She continues to give lectures on management of mental health care in pediatric primary care to the Mass General pediatric residents.

Abstract: A New Curriculum for Enhancing Pediatric Mental Health Treatment in Primary Care Settings


Doreen DeFaria Yeh, MD, FACCDoreen DeFaria Yeh, MD, FACC
Department of Medicine, Cardiology Division
Assistant Professor of Medicine, Harvard Medical School

Dr. DeFaria trained in Internal Medicine at the Massachusetts General Hospital, and in Cardiovascular Medicine, Echocardiography and Adult Congenital Heart Disease (ACHD) at the University of California San Francisco. She joined the Mass General Cardiology staff in 2010 and currently serves as the Director of the Mass General Cardiovascular Disease Fellowship Program. Other important roles include Associate Director of the Mass General ACHD Program and Co-Director of the Mass General Cardiovascular Disease and Pregnancy Program. Nationally, she chairs the American Heart Association Laennec Post-Graduate Education Committee. She participates in several departmental committees including the Diversity and Inclusion Board. She presently serves as the Faculty Chair of the Women in Medicine Trainees Council. Dr. DeFaria was selected as an American College of Cardiology Emerging Faculty (2012) and has received the Eleanor and Miles Shore Award through Harvard Medical School (2012), the Clinician Teacher Development Award through the Center for Diversity and Inclusion (2013), the Mass General Cardiology Division’s Clinical Scholar Award (2016) and is a multiple recipient of the Brian A. McGovern Memorial Award for Excellence in Clinical Care and Teaching, and most recently the Mass General Cardiovascular Fellowship for Excellence in Clinical Teaching. Education is a primary focus of her efforts and she has co-directed several continuing medical education courses including the Mass General ACHD Course, as well as the Mass General Multidisciplinary Care of the Pregnant Patient with Heart Disease Course.

Abstract: Redefining Adult Congenital Heart Disease Education in Massachusetts

Due to major advances in congenital heart surgery and pediatric intensive care over the past sixty years, the number of adults living with congenital heart disease (ACHD) has risen sharply. Currently, in the US there are more adults living with CHD than children and the ACHD population is expected to increase by 5% per year. As a result of this rapid growth, ACHD hospital admissions and health care expenditures have markedly increased. Paradoxically, cardiologists express that ACHD remains a major area of weakness or is a “black box” and feel uncomfortable managing these patients without subspecialty support.

ACHD didactic and clinical experiences for cardiology fellows vary widely. National exam scores demonstrate lowest overall performance by adult cardiology fellows on CHD topics. Few programs offer advanced ACHD training, and the number of specially trained physicians is unlikely to meet projected workforce requirements as this population grows and ages. Deficiencies in adult cardiology fellow and staff education must be urgently addressed in core cardiology training. With the support of the Clinician Teacher Development Award Dr. DeFaria published a Handbook and EBook that serves as a reference for fellows and general cardiologists, Adult Congenital Heart Disease in Clinical Practice was published by Springer in 2018. She is extraordinarily grateful to MGH, the MGPO, Dr. Slavin and the Center for Diversity and Inclusion which supported completion of this project.


Jocelyn Carter, MD, MPHJocelyn Carter, MD, MPH
Department of Medicine, General Internal Medicine Division, Albright/Hospital Medicine Unit
Assistant Professor in Medicine, Harvard Medical School

Dr. Carter obtained her BA from Harvard University in 2001 and her MD from the University of Illinois at Chicago College of Medicine in 2006. She completed her medical residency training at Dartmouth-Hitchcock Medical Center, Lebanon, NH in 2009. In 2011, she completed a Leadership Preventive Medicine Fellowship at Dartmouth-Hitchcock Medical Center and received her Masters in Public Health from The Dartmouth Institute for Health Policy and Clinical Practice in Lebanon, NH. Clinically prepared in internal medicine and preventive medicine, Dr. Carter is a practicing internal medicine hospitalist (Albright Medicine) and physician-scientist within the MGH Division of General Internal Medicine (DGIM). Her primary research interests include patient-centered and innovative care delivery models that improve health outcomes for vulnerable patients with serious-illness through evidence-based interventions. Dr. Carter is particularly interested in clinical and social determinants of health-related interventions that leverage technology while promoting prevention, the subject of her NHLBI K23 award. Dr. Carter serves as the MGH Center for Diversity and Inclusion Manager of Trainee Affairs and as the DGIM Director of Research Equity. She is an active member of the MGH Department of Medicine Diversity and Inclusion Board, the DOM Community Council and the MGH ECOCH Social Determinants of Health Subcommittee. Dr. Carter also enjoys being a member of the MGPO Clinical Performance and Contracting Committee, the ABIM American Board of Preventive Medicine Public Health Committee, and the Contemporary Clinical Trials Editorial Board.

Abstract: Reducing 30-day Hospital Readmissions in an Academic Medical Center

The major project focus is the study of readmissions patters to reduce readmissions on two inpatient medical units. In the era of health care reform and increasing emphasis on higher quality healthcare at lower costs, the importance of care delivery during and after hospitalizations has been magnified. With over 13 million hospitalizations driving $102 billion in health care costs in 2004, rates of hospitalization have become a measure of keen interest. In 2004, there were 2.3 million hospital readmissions (19%) among Medicare enrollees within 30 days of a previous discharge generating over $17 billion in health care costs. Up to $12 billion of these costs (70%) have been attributed to preventable rehospitalizations. The discovery and validation of meaningful interventions and analytic tools structured to reduce hospital readmissions and meet the needs of hospitalized populations remains understudied and additional resources are needed to create valuable solutions. Primary aims of this project include 1) validating an analytic tool that can be used to identify patients with increased risk for 30-day readmission; 2) examining the patterns of patient and provider perceptions around discharge and post-hospital care among patients admitted to the AHS; and 3) characterizing the effect of interventions on readmission patterns for patients at increased risk for readmissions. The results of this work are expected to contribute to protocols that may be provide critical insights and improved strategies of reducing hospital readmissions locally and nationally.


Luana Marques, PhDLuana Marques, PhD [PHS IS2]
Department of Psychiatry, Division of Psychology 
Director, Community Psychiatry PRIDE
Associate Director and Director of Research, Center for Anxiety and Traumatic Stress Disorders (CATSD)

Assistant Professor of Psychology in Psychiatry, Harvard Medical School

Dr. Marques is the Director of Community Psychiatry Program for Research in Implementation and Dissemination of Evidence-Based treatments (PRIDE) at Massachusetts General Hospital. She is also an Associate Professor in Psychiatry at Harvard Medical School. Dr. Marques completed her PhD in Clinical Psychology at the State University of New York (SUNY) at Buffalo and her clinical internship in the Cognitive Behavioral track (CBT) at Massachusetts General Hospital/Harvard medical School in 2007.

Dr. Marques’ major clinical and research interests include the implementation and dissemination of evidence-based treatments in diverse, low-income settings. Specifically, she is interested in reducing mental health disparities for individuals in communities across Massachusetts by bridging the gap between scientific innovation and real-world clinical practice. Dr. Marques received a Multicultural Affairs Office (MAO) award from Mass General for Clinician-Teacher Development, from which she worked to develop an evidence-based teaching program at MGH Chelsea HealthCare Center for clinicians who are actively treating patients with posttraumatic stress disorder (PTSD). Additionally, she has worked with the youth development organization, Roca, to develop and adapt an evidence-based treatment of cognitive behavioral therapy to be delivered by paraprofessionals to young men involved in the criminal justice system. Dr. Marques is currently working on a multi-site study to develop a novel assessment tool for CBT quality in community mental health settings.

Abstract: Creating a Teaching Program for Evidence Based Therapy for PTSD in Community Mental Health: Bridging the Science-Practice Gap

The core aim of the proposed teaching plan is to bridge the science-practice gap, by creating a community participatory teaching program that is designed to teach an empirically-based treatment, namely Cognitive Processing Therapy (CPT), to clinicians who are actively treating patients diagnosed with posttraumatic stress disorder (PTSD) at the MGH-Chelsea Community Mental Health Center (MGH-Chelsea). PTSD is a highly prevalent disorder and is associated with significant individual and societal burden. Empirically based treatments (EBTs) for PTSD, such as CPT, have demonstrated efficacy and effectiveness. However, efforts to implement EBTs for PTSD in CMHCs have been largely ineffectual due, in part, to complex barriers to implementation. one such barrier is the lack of integration between academic medicine and clinical practice in the “real world.” often, even cutting-edge teachers and researchers fail to bring their knowledge into the typical practice settings, which in turn contributes to the average of 10 years’ gap between advances in science and practice in the clinic.

The current project proposes to decrease the science-practice gap by applying the candidate’s clinical, teaching and research expertise to develop a means of effectively teaching cognitive processing therapy to community mental health workers (CMHWs) to ultimately improve clinical outcomes for patients suffering from PTS. This CTDA award will allow the candidate to create a novel teaching curriculum designed to bring EBT to community care settings.


Erica Wilson, MD
Department of Medicine, Division of Palliative Care
Instructor in Medicine, Harvard Medical School

Dr. Wilson obtained her BA in Computer Science and Chemistry from Mount Holyoke College and her MD from the University of California San Francisco. She completed her internal medicine and chief residencies at Cambridge Hospital in Cambridge, MA. She received subspecialty training in the Harvard Palliative Medicine Fellowship and then joined the Massachusetts General Hospital Division of Palliative Care as an attending in September 2009. She is an Instructor in Medicine at Harvard Medical School. She is the lead for technology and learning for the MGH Continuum Project. The project provides primary palliative care training with a goal to improve care for patients with serious illness. Her interests include medical informatics, patient safety, cross cultural medicine and Palliative Medicine for the underserved. Her research focused on Palliative Medicine for the homeless. Current research focuses on medical communication skills and racism and inequity in Palliative Care and Geriatric Medicine. She enjoys gardening, teaching and learning and spending time with her son.

Abstract: Dying Without a Home: Understanding and responding to disparities in palliative and end of life care among the homeless

The field of Palliative medicine strives to improve the quality of life of patients and their families facing life- threatening illness, through the prevention, assessment and treatment of pain and other physical, psychological and spiritual problems. Social inequity, especially poverty, is a major risk factor for people to experience both suffering and premature death. These very populations also have limited access to quality palliative and end of life care. There is a dearth of research to inform the development education, advocacy, public health and clinical innovation in these areas. We will conduct semi-structured interviews of three homeless patients receiving end of life care at the Barbara McInnis House (BMH) in Boston. Interviews will focus on their experiences and the quality of care received as well as their attitudes and concerns about end of life to determine themes and the unique issues involved in dying without a home. We will conduct a chart review of the previous three patients who received end of life care and died at the BMH. We will enroll 20 terminally ill homeless patients receiving care at the BMH and administer a survey about their attitudes and EOL concerns. Using the combined clinical expertise of the Palliative Care Service (PCS) at Massachusetts General Hospital (MGH) and Boston Healthcare for the Homeless Program (BHCHP) we will create a curriculum and clinical protocols for providing palliative and end of life care to the homeless. Using the results of this work and the expertise within the MGH PCS in internal palliative care, we will extend the Harvard Palliative Medicine Fellowship (HPMF) to also focus on the provision of care to marginalized patient populations such as homeless individuals and those in developing countries.


Wendy Macías-Konstantopoulos, MD, MPHWendy Macías-Konstantopoulos, MD, MPH
Associate Physician in Emergency Medicine
Director, Center for Social Justice and Health Equity
Executive Director, Mass General Freedom Clinic
Department of Emergency Medicine, Massachusetts General Hospital
Associate Professor of Emergency Medicine, Harvard Medical School

Dr. Wendy Macías-Konstantopoulos, MD, MPH is Associate Physician in Emergency Medicine at Massachusetts General Hospital (MGH) and Associate Professor of Emergency Medicine at Harvard Medical School. She holds a Masters in Public Health from the Harvard T.H. Chan School of Public Health and completed the Global Health Leadership Fellowship at MGH. She is Director of the Human Trafficking Initiative at MGH and founding Executive Director of the Mass General Freedom Clinic for survivors of human trafficking ages 13 and older. Her clinic is winner of the 2014 Partnership for Freedom Reimagine Opportunity national grant competition and recipient of a 2016 Partners in Excellence Team Award.

Recognized as an early pioneer and leading national expert in hospital-based anti-trafficking public health efforts, her knowledge and expertise have been sought by hospital systems across the country and among others, the American Hospital Association, American College of Emergency Physicians, Massachusetts Governor’s Council on Sexual Assault and Domestic Violence, U.S. Department of Health and Human Services, and the National Human Trafficking and Technical Assistance Center where she serves as an expert consultant.

In the past, Dr. Macías-Konstantopoulos volunteered with the International Organization for Migration’s Counter-Trafficking Unit in Indonesia, and represented the MGH Center for Global Health at the United Nations 2008 Global Forum to Fight Human trafficking in Vienna, Austria. She is the five-term Chair of the Massachusetts Medical Society’s Committee on Violence Intervention and Prevention, and was honored with the Massachusetts Medical Society Honor Roll Award for her commitment to ending violence in all its forms.

Abstract: Redefining and Responding to Human Trafficking as a Global Public Health Issue

Human trafficking is an egregious violation of human rights associated with profoundly devastating physical and mental health outcomes. The trafficking of adults and children has been reported in all 50 states, U.S. territories, and the District of Columbia. Research confirms that a large proportion of trafficking survivors access medical care during their exploitation.

The goals of her CTDA project were to: 1) perform a contextual analysis of human trafficking in the Boston area;† 2) identify gaps and opportunities by mapping out the current local health and social services available for this survivor population; 3) assess clinician knowledge of this form of violence; 4) provide education and training on human trafficking for healthcare professionals; and 5) identify ways in which hospitals can play a unique role in preventing and responding to human trafficking victims in the healthcare setting, with the long-term vision of establishing a clinical program for survivors of human trafficking. The founding of the Mass General Freedom Clinic 1.5 years following completion of her project was the pinnacle achievement made possible by the CTDA.

†Macias-Konstantopoulos WL, Munroe D, Purcell G,Tester K, Burke TF,Ahn R. The Commercial Sexual Exploitation and Sex Trafficking of Minors in the Boston Metropolitan Area: Experiences and Challenges Faced by Front-Line Providers and Other Stakeholders. Journal of Applied Research on Children. 2015;6(1):4.


Alexy Arauz Boudreau, MD, MPH, FAAPAlexy Arauz Boudreau, MD, MPH, FAAP
Assistant Professor of Pediatrics, Harvard Medical School
MGHfC Medical Director of Primary Care and Population Health Management
MGH/MGPO Medical Director, Medicaid Accountable Care Organization

Dr. Arauz Boudreau is an academic community pediatrician with a focus on improving the health of vulnerable populations through primary care re-design, research and community initiatives. As the Medical Director for Primary Care and Population Health Management at the Massachusetts General Hospital for Children, leading primary care restructuring efforts to respond to the needs of 21 Century healthcare. She has taken a lead role in transforming MGHfC pediatric primary care practices into patient centered medical homes implementing population health management and quality improvement efforts to develop a holistic system for promoting child well-being. For vulnerable children and adolescents who require significantly more health care services, she spearheaded the development of the MGH pediatric integrated care management program to enhance primary care providers’ ability to coordinate the delivery of patient care services along the continuum of health care across multi-disciplinary sectors, and through an interdisciplinary team approach. After leading the initial pediatric response to the MassHealth Medicaid ACO at the Massachusetts General Hospital this past February she was asked to become the Medical Director for MassHealth Medicaid ACO at the Massachusetts General Hospital as part of the Partners ACO, Partners HealthCare Choice.

Dr. Arauz Boudreau practices primary care pediatrics at MGH Chelsea HealthCare Center. She received her medical degree from Harvard Medical School and a Master’s in Public Health from the Harvard School of Public Health. She has completed the Harvard Pediatric Health Services Research Fellowship and the Mangan Commonwealth Fund/Harvard University Fellowship in Minority Health Policy.

Abstract: The Evaluation of Healthy Steps MGH: Promoting Healthy Child Development and the Reduction of Health Disparities Through an Office-Based Intervention

Early life experiences are important in predicting the emotional and physical well-being of both children and adults. By setting life-health trajectories, early childhood influences health disparities and offers an opportunity to address disparities through enhancing childhood development. Healthy Steps is one model by which pediatricians can augment preventative childhood health and development. It places child developmental specialists in pediatric practices, coupling well-child visits with parental education. We aim to explore the effects of Healthy Steps on child development and how it may affect school readiness, obesity, mental health and disparities in these outcomes. A case-control study of the MGH Healthy Steps will assess differences among families that receive Healthy Steps and those that do not, as well as differences across racial/ethnic and socio-economic groups. One hundred cases families and 300 controls (1:3 case:control) that speak either English or Spanish will be enrolled prior to the child’s four-year-old well-child visit. Outcomes will be assessed using established instruments to compare scores across groups. By demonstrating that developmental specialists can assist pediatricians in improving school readiness and reducing precursors of obesity and mental health, we can move beyond describing health disparities to reducing them and argue for preventative health interventions focused on early childhood.


Marcela G. del Carmen, MD, MPHMarcela G. del Carmen, MD, MPH
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology
Interim MGPO President
Chief Medical Officer, MGH and MGPO
Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School

Dr. del Carmen, MD, MPH is Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and currently serves as Interim President of the Massachusetts General Physicians Organization (MGPO) and Chief Medical Officer for both MGPO and MGH. In her role, Dr. del Carmen leads over 3,000 MGPO physician members. She graduated from medical school and completed her residency training in gynecology and obstetrics at Johns Hopkins School of Medicine and Hospital and fellowship training in gynecologic oncology at Massachusetts General Hospital. Dr. del Carmen holds a Masters in Public Health from Harvard School of Public Health. She has served on the Ovarian Cancer Committee for the Gynecologic Oncology Group, is a member of the American Board of Obstetrics and Gynecology PROLOG task force, and serves as oral examiner for the American Board of Obstetrics and Gynecology (ABOG) for both general gynecology and gynecologic oncology. She is on the Board of Directors of the Society of Gynecologic Oncology, the Gynecologic Oncology Division of ABOG, the Faculty Council and the Main Committee of Admissions at Harvard Medical School. Dr. del Carmen is co-founder and co-Chair of the Women First Research Coalition for the American Gynecological and Obstetrical Society.

Dr. del Carmen has authors over 250 papers in the peer-reviewed literature and has authored a textbook. Dr. del Carmen is the recipient of numerous teaching and service awards including the National Council on Resident Education in Obstetrics and Gynecology (CREOG) Award, the Howard Ulfelder Teaching Award, the CINE Golden Eagle Award, CBS Cares, and the McGovern Award for Clinical Excellence. Dr. del Carmen’s research focuses on disparities in gynecologic cancer outcomes in underserved minorities with rare gynecologic malignancies.

Abstract: Understanding Barriers to Cervical Cancer Screening Among Hispanic Women in Boston

Latino women in the United States disproportionately shoulder the burden of cervical cancer. The higher incidence of cervical cancer which has been documented among Latino women in the United States is partly due to the lower rates of participation with Pap smear screening programs among Latino women in the United States. The project’s hypothesis is that improving compliance with Pap smear screen among Latino women necessitates the design of more culturally appropriate educational materials to better disseminate information about the role of Pap smear screening in the prevention of cervical carcinoma. In addition it is also hypothesized that elimination of currently existing disparities in health care mandates the institution and dissemination of culturally competent skills among health care providers. The funding from the Clinician- Teacher Development Award has the three following interrelated goals:

  1. To investigate the demographics of screening that Latino women in the Boston area have and their perception of the role of Pap smears in cervical cancer screening
  2. To design educational materials and health promotion strategies in increasing compliance with Pap smear screening in a defined community-based cohort
  3. To design a culturally competent curriculum to educate health care givers who provide cervical cancer screening to Latino


Rocío Hurtado, MD, DTM&HRocío Hurtado, MD, DTM&H
Director, Mycobacterial Center of Excellence, Infectious Disease Division, Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School

Dr. Rocío Hurtado is a graduate of the Johns Hopkins University School of Medicine and completed her Internal Medicine Residency at the Massachusetts General Hospital. She also trained in Infectious Disease at the combined MGH/BWH ID Fellowship program (including a Clinical HIV fellowship), and is board-certified in Internal Medicine and Infectious Disease. In addition, she obtained a Diploma in Tropical Medicine and Hygiene from the Liverpool School of Tropical Medicine in the United Kingdom. In 2002, she received the Edward Kass Award for Clinical Excellence in Infectious Disease from the Massachusetts Infectious Disease Society. Dr. Hurtado has an active interest in HIV/TB coinfection in resource-limited settings with a focus on multidrug-resistant tuberculosis (MDRTB), as well as the clinical interface of HIV and tropical medicine. She has had extensive overseas experience since 2002 as an Infectious Disease Consultant in the Community-based Management of Multidrug Resistant Tuberculosis Project with Partners in Health in Lima Peru. In 2003, she was selected as an HIV trainer for the Academic Alliance for AIDS Care and Prevention in Africa, a collaborative effort between Makerere University (Kampala, Uganda) and the Infectious Disease Society of America. Since 2005 she has also established collaborative ties in South Africa focusing on HIV/TB coinfection & Global Health education for medical residents, jointly with her colleagues Dr. Krista Dong and Dr. Douglas Wilson. She has been the Director of the Mycobacterial Center at MGH since 2004 and previously served as the Associate Program Director for Global Health in the Department of Medicine at MGH (2005-2014). She is also the Primary Course Director for the two sentinel ID courses on Vector & Zoonotic Infection and Food and Water-related infections in the Global Infectious Disease Certificate Program at the Harvard School of Public Health and Harvard Medical School. She is the recipient of numerous teaching awards (including three-times winner of the Faculty award in ID teaching) and the Brian McGovern Award in Clinical Excellence at MGH. Since 2010, Dr. Hurtado has also worked as the Clinical and Technical Advisor to the Global Health Committee with its sentinel sites in Ethiopia and Cambodia and their MDRTB programs (in partnership with the Ministry of Health).

Abstract: A Clinical and Teaching Service Project for Mycobacterial Disease and HIV Coinfections

With the support of her MGH Development award and mentorship from Drs. Nesli Basgoz and Paul Farmer, Rocio Hurtado’s proposed project has 2 stages. The first phase of her award has been dedicated to implementing the MGH’s Mycobacterial Center which provides centralized clinical care for patients living with mycobacterial diseases (including TB, non-tuberculous mycobacteria and Hansen’s disease), cross-disciplinary expertise and clinical teaching (through Mycobacterial training of ID fellows and monthly multidisciplinary Case Conferences including multiple subspecialties at MGH). In the second phase of her project, she is developing a locally-relevant HIV/TB didactic module in conjunction with the Peruvian Ministry of Health, to later serve as a platform for training of different health-care sectors and which can be modified and adapted to other resource limited settings.